Chlorpyrifos Oxon Activates Glutamate and Lysine for Protein Cross-linking.
Diego Muñoz-TorreroLawrence M SchopferOksana LockridgePublished in: Chemical research in toxicology (2023)
Chronic low-dose exposure to organophosphorus (OP) toxicants is correlated with an increase in the risk of impaired cognition and neurodegenerative diseases. A mechanism to explain this relationship is needed. We suggest that the formation of organophosphate-induced high-molecular-weight protein aggregates that disrupt cell function may be the missing link. It has been demonstrated that such aggregation can be promoted by OP-labeled lysine. Alternatively, OP-labeled glutamate may be the initiator. To test this hypothesis, we treated MAP-rich tubulin Sus scrofa and human transglutaminase with chlorpyrifos oxon. Trypsin-digested proteins were subjected to liquid chromatography-tandem mass spectrometry followed by Protein Prospector searches to identify diethyl phosphate adducts and cross-linked peptides. We report the presence of diethyl phosphate adducts on the side chains of glutamate, lysine, and tyrosine, as well as cross-links between glutamate and lysine. Glutamate-lysine cross-linking could be initiated either by diethyl phosphate-activated glutamate or by diethyl phosphate-activated lysine to form stable isopeptide bonds between and within proteins. It was concluded that organophosphate-induced high-molecular-weight protein aggregates could promote brain dysfunction.
Keyphrases
- amino acid
- liquid chromatography tandem mass spectrometry
- low dose
- protein protein
- diabetic rats
- binding protein
- multiple sclerosis
- pet imaging
- ms ms
- computed tomography
- heavy metals
- high dose
- mild cognitive impairment
- mass spectrometry
- risk assessment
- solid phase extraction
- induced pluripotent stem cells
- positron emission tomography
- high density